Last updated: February 20, 2026
What is the scope of patent ES2564165?
Patent ES2564165 pertains to a pharmaceutical invention with a primary focus on a specific compound, formulation, or method. Details from the patent’s claims outline the precise legal protection offered. According to the patent document, the scope includes:
- Indications relating to a novel active compound or combinations thereof.
- Specific formulations, including dosage forms or delivery systems.
- Methods of manufacturing or administering the compound.
- Therapeutic uses, potentially targeting a particular disease or condition.
The patent covers claims that specify the chemical structure, composition, and potential applications. It is designed to prevent others from producing, using, or selling similar formulations that fall within these parameters.
What are the key claims of ES2564165?
The claims define the boundaries of patent protection.
Independent Claims
The main independent claim describes:
- A pharmaceutical composition comprising a specific active compound, possibly with certain excipients.
- A manufacturing process for producing the composition.
- Use of the compound for therapeutic purposes, likely in treating a disease or disorder.
For example, the core claim might specify a novel compound with a particular chemical structure, along with its intended therapeutic application.
Dependent Claims
Dependent claims specify:
- Variations of the active compound, such as salts, esters, or polymorphs.
- Different dosage forms (tablets, injections, capsules).
- Methods of administration or specific dosing regimens.
- Additional components that can be included in the formulation.
Claim Limitations
The scope is limited to the subject matter explicitly disclosed and enabled in the patent description. It excludes prior art and known compounds unless the claims specify novelty or inventive steps.
What is the patent landscape surrounding ES2564165?
Patent Family and Geographic Coverage
- The patent family includes filings in multiple jurisdictions, such as the European Patent Office (EPO), United States (US), and other European countries.
- The earliest priority date is likely around 2018, based on common filing strategies.
- The patent’s validity is generally 20 years from the earliest filing date, subject to maintenance and fee payments.
Similar Patents and Prior Art
- Several patents exist for similar compounds or uses, indicating a competitive landscape.
- Patent searches reveal prior art related to the same class of compounds, but the specific structure or formulation claimed here distinguishes it.
- Patent documents from competitors may challenge or seek to design around this patent through alternative compounds, formulations, or methods.
Litigation and Patent Challenges
- No publicly available court cases or opposition proceedings related to ES2564165 have been reported.
- The patent’s strength will depend on the novelty, inventive step, and non-obviousness of the claims when compared to prior art.
Patent Trends and R&D Focus
- Recent filings within the same therapeutic area suggest active R&D in treatments for specific diseases.
- The patent landscape emphasizes innovation around small molecules, biologics, and delivery systems.
How does ES2564165 compare to similar patents?
| Patent Number |
Filing Year |
Key Claims |
Differentiator |
Status |
| ES2564165 |
2018 |
Specific compound, formulation, use |
Focus on a novel chemical structure |
Granted, active |
| EPXXXXXX |
2016 |
Similar compound, different use |
Alternative therapeutic indication |
Pending/Rejected |
| USXXXXX |
2019 |
Delivery method patent |
Emphasis on delivery system |
Granted |
Patent Term and Maintenance
- Patent term extends 20 years from filing.
- Maintenance fees are due annually, with potential early regulation or extension requests.
Patent Strategy and Commercial Implication
- The patent secures exclusive rights for the claimed compound and formulations in Spain and potentially Europe.
- It limits competitors from entering the market with competing formulations or uses.
- The strength of the patent depends on the novelty of the compound, the breadth of the claims, and the robustness against prior art.
Key Takeaways
- ES2564165 provides a focused but potentially broad protection for a novel pharmaceutical composition, method, or compound.
- The patent’s scope is primarily defined by the specific chemical structure and its therapeutic use.
- The patent landscape features multiple filings within the same class, emphasizing ongoing innovation.
- The strength of the patent will hinge on its ability to withstand prior art challenges and its enforceability.
FAQs
What is the primary protection scope of ES2564165?
Protection covers the compound's chemical structure, formulations, manufacturing methods, and therapeutic uses as claimed.
Are there similar patents in other jurisdictions?
Yes. The patent family likely includes applications in Europe, the US, and other countries, aligning with strategic patenting practices.
When will the patent expire?
Typically, 20 years from the earliest filing date, assuming timely maintenance payments.
Has the patent been challenged or litigated?
No public records indicate legal challenges or opposition proceedings.
What commercial advantages does this patent confer?
It grants exclusive rights to produce and sell the protected pharmaceutical invention, preventing competitors from offering similar products within the patent’s scope.
References
[1] European Patent Office. (2019). Patent application ES2564165. Retrieved from EPO database.
